IL-1β and IL-2 convert human Treg into TH17 cells
Introduction
Until recently, in both mice and humans, CD4+ T cell effectors have been classified in TH1 and TH2 type cells [1]. TH1 cells mainly produce IFN-γ, are responsible for protection against intracellular pathogens and cancer and have been classically considered as the main subset involved in autoimmune diseases, whereas TH2 cells produce IL-4, IL-5 and IL-13, are responsible for protection against extra-cellular parasites, and are believed to be mainly involved in the development of allergic disorders. Recently, however, the existence of additional CD4+ T cell lineages has been clearly documented. Among these, CD4+CD25+ natural regulatory T cells (Treg) have been described as a distinct lineage of anergic and suppressor cells arising in the thymus and characterized by the constitutive expression of the transcriptional suppressor FOXP3 [2], [3]. In both animal models and in humans, Treg have been shown to be in charge of controlling self-tolerance, constitutive absence or functional depletion of the subset resulting in autoimmunity [4], [5]. Among human circulating lymphocytes, natural Treg populations are readily distinguishable from CD25+ activated CD4+ T cells based on their ex-vivo CD127lowFOXP3+ phenotype [6] and are present both at the naïve and memory stages [7]. In addition, lately, a distinct type of CD4+ helper T cells (TH17 cells) producing IL-17, a pro-inflammatory mediator that stimulates the production of chemokines and anti-microbial peptides and leads to the recruitment of neutrophils, has received much attention [8]. Apart from their protective role towards extra-cellular microbial invasion, TH17 cells have been clearly shown to be involved in autoimmune pathology, in studies using murine models of experimental autoimmune encephalomyelitis (EAE) and collagen-induced arthritis (CIA), two experimental autoimmune diseases that had been previously attributed to unchecked TH1 responses [8], [9], [10], [11]. Furthermore, recent findings of high numbers of IL-17 mRNA-expressing cells and high levels of secreted IL-17 in patients with several autoimmune diseases, are highly indicative of the involvement of TH17 cells in human autoimmune disorders [12]. In healthy donors, a population of CD4+ T cells producing IL-17 ex-vivo has been recently identified in circulating lymphocytes from healthy individuals, among memory CD4+ T cells, mainly in the CCR6+ fraction, but not among naive CD4+ T cells [13], [14]. TH17 cells with similar phenotypical and functional characteristics have also been found in the gut of Crohn's disease patients [14]. Both mouse and human TH17 populations are characterized by high expression of the transcription factor RORγt [13], [14], [15].
Consistent with the opposite immune functions carried out by Treg and TH17 cells, several studies have reported the existence of reciprocal developmental pathways for these two subsets. Thus, at least in mice, TGF-β1 alone promotes the differentiation of Treg, whereas the association of IL-6 and TGF-β1 has been reported to inhibit the differentiation of Treg and to promote the differentiation of TH17 cells [16], [17]. In humans, TH17 differentiation from naïve CD4+CD25− T cells has been initially suggested to be induced by IL-1β and IL-6 but suppressed by TGF-β [18], [19]. However, recent reports have shown that TGF-β1 in combination with IL-21 or with IL-1β and IL-23 induces differentiation of TH17 cells from human naïve CD4+ T cells [20], [21], [22]. IL-2, that is indispensable for the development of Treg [23], has been initially reported to inhibit the differentiation of TH17 cells both [18], [24]. However, this effect is abolished in the presence of IL-1β [25] and, under these conditions, IL-2 has instead a positive effect on IL-17 production by human CD4+ T cells [20].
Together, the results of these studies have suggested the existence of not only a functional antagonism between the Treg and TH17 subsets, but also of a dichotomy, mutually exclusive, in their generation. The relationship between the two subsets, however, is complex and has not been completely elucidated. In particular, the analysis of the interplay between the two subsets during chronic inflammation, that often leads to the development of autoimmune pathology, is of great interest.
Whereas under physiologic conditions natural Treg are anergic and suppressor, different factors, including cytokines produced under inflammatory conditions, TLR stimulation, or interaction with activated APC, have been shown to be able to abrogate their suppressive effects, resulting in autoimmune reactions [26], [27], [28], [29]. Because many of the factors that influence the development of natural Treg are also involved in the differentiation of TH17 cells, we addressed if stimulation of Treg under TH17 polarizing conditions, in the presence of factors that break their anergy, could convert them into TH17 cells. In the present study, we report that stimulation of human Treg in the presence of activated monocytes and IL-2 induced their conversion into TH17 cells. The conversion was mediated by IL-1β, was dependent on the presence of IL-2, and involved down-regulation of FOXP3 and suppressor functions. It occurred from both natural naïves and, to a larger extent, from memory Treg. Together, our results indicate that, under inflammatory conditions, in the presence of IL-2, natural Treg can be converted into TH17 cells by IL-1β-producing APC, lose their suppressor function, and may contribute instead, both directly and/or indirectly, to the autoimmune pathology.
Section snippets
Samples, cell purification and sorting
Peripheral blood samples were obtained from the Etablissement Français du Sang Pays de la Loire (Nantes, France). Peripheral blood mononuclear cells (PBMC) were isolated by density gradient sedimentation using LSM 1077 lymphocyte separation medium (PAA laboratories GmbH, Pasching, Austria). CD4+ T cells and CD14+ monocytes were enriched by positive selection from PBMC by magnetic cell sorting (Miltenyi Biotec Inc., Bergisch Gladbach, Germany). For flow cytometry cell sorting, enriched CD4+ T
Stimulation of Treg with activated monocytes in the presence of IL-2 converts them into TH17 cells
We have previously shown that human circulating natural CD4+CD25+ regulatory T cells can be distinguished into memory (CD45RA−) and naïve (CD45RA+CCR7+, called NnTreg) populations [7]. To address if human Treg stimulated under TH17 polarizing conditions could give rise to IL-17-producing cells, we isolated naïve (CD45RA+) and memory (CD45RA−) conventional (CD25−) and Treg (CD25+) CD4+ T cell populations to a high degree of purity by flow cytometry cell sorting. We used the CD127 marker to
Discussion
Several recent studies have indicated the existence of a close interplay between Treg and TH17 cells in regulating some autoimmune diseases. Whereas murine Treg suppress both TH1 and TH2 cells, they do not suppress, but may instead enhance IL-17 secretion by T cells, likely through production of TGF-β [30], [31]. Similarly, differentiation of conventional human CD4+ T cells into TH17 cells is enhanced in the presence of natural Treg [19]. Using stimulation with LPS-activated monocytes we have
Acknowledgments
We would like to thank Mrs. Naira Souleimanian, Isabelle Raimbaud, Lucie Leveque and Christelle Dousset for excellent technical assistance. The study was supported by the Ludwig Institute for Cancer Research (USA), the Cancer Research Institute (USA), the Institut National de la Santé et de la Recherche Médicale (France), the Institut National du Cancer (France), the Conseil Régional des Pays de la Loire (France) and the European Structural Funds (FEDER program).
References (47)
- et al.
Th17: an effector CD4 T cell lineage with regulatory T cell ties
Immunity
(2006) - et al.
Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17
J. Biol. Chem.
(2003) - et al.
The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells
Cell
(2006) - et al.
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Immunity
(2007) - et al.
TNF downmodulates the function of human CD4+CD25hi T-regulatory cells
Blood
(2006) - et al.
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells
Immunity
(2006) - et al.
Differential expression of CCR7 defines two distinct subsets of human memory CD4(+)CD25(+) Tregs
Clin. Immunol.
(2008) Good for Goose, but not for Gander: IL-2 interferes with Th17 differentiation
Immunity
(2007)- et al.
Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases
Cell
(2004) - et al.
The lineage decisions of helper T cells
Nat. Rev., Immunol.
(2002)
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Nat. Immunol.
Control of regulatory T cell development by the transcription factor Foxp3
Science
Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
J. Immunol.
Control of intestinal inflammation by regulatory T cells
Immunol. Rev.
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
J. Exp. Med.
A peripheral circulating compartment of natural naive CD4 Tregs
J. Clin. Invest.
Cutting edge: C3, a key component of complement activation, is not required for the development of myelin oligodendrocyte glycoprotein peptide-induced experimental autoimmune encephalomyelitis in mice
J. Immunol.
IL-12p35-deficient mice are susceptible to experimental autoimmune encephalomyelitis: evidence for redundancy in the IL-12 system in the induction of central nervous system autoimmune demyelination
J. Immunol.
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Mult. Scler.
Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells
Nat. Immunol.
Phenotypic and functional features of human Th17 cells
J. Exp. Med.
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
Nature
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells
Nature
Cited by (152)
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis
2023, Rheumatic Disease Clinics of North AmericaThe impact of donor diabetes on corneal transplant immunity
2023, American Journal of TransplantationOsteoimmunology: The Crosstalk between T Cells, B Cells, and Osteoclasts in Rheumatoid Arthritis
2024, International Journal of Molecular Sciences
- 1
D.V. and M.A. share senior authorship.